RA CAPITAL MANAGEMENT, L.P.
Total Volume
$693.6M
50 filings
Purchases
$539.9M
35 buy txns
Sales
$95.0M
22 sell txns
Net Activity
$444.9M
net bought
Profile
- Filings
- 50
- Buy transactions
- 35
- Sell transactions
- 22
- Companies
- 23
- Active
- 2026
Across 50 filings between 2026, RA CAPITAL MANAGEMENT, L.P. has disclosed $693.6M in transactions — spread across 23 companies. Their disclosed trades are heavily weighted toward buying — $539.9M in buys and $95.0M in sells. The largest single open-market purchase on record is $423.8M in Parabilis Medicines, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Parabilis Medicines, Inc. (PBLS)
4 filings
$431.1M
$430.7M bought
Septerna, Inc. (SEPN)
2 filings
$64.0M
Freenome, Inc. (FRNM)
2 filings
$52.6M
Bambusa Therapeutics, Inc. (BBTX)
2 filings
$46.6M
$46.6M bought
PepGen Inc. (PEPG)
2 filings
$43.2M
$43.1M bought
Sionna Therapeutics, Inc. (SION)
2 filings
$22.5M
Artiva Biotherapeutics, Inc. (ARTV)
11 filings
$18.0M
$17.7M bought
LENZ Therapeutics, Inc. (LENZ)
2 filings
$9.3M
Climb Bio, Inc. (CLYM)
3 filings
$1.8M
Hemab Therapeutics Holdings, Inc. (COAG)
1 filing
$1.7M
$1.7M bought
Vor Biopharma Inc. (VOR)
4 filings
$836.4K
Werewolf Therapeutics, Inc. (HOWL)
3 filings
$573.2K
Bicara Therapeutics Inc. (BCAX)
1 filing
$400.4K
ARS Pharmaceuticals, Inc. (SPRY)
1 filing
$316.2K
Wave Life Sciences, Inc. (WVE)
1 filing
$240.0K
Janux Therapeutics, Inc. (JANX)
1 filing
$211.7K
Acumen Pharmaceuticals, Inc. (ABOS)
1 filing
$121.9K
Nkarta, Inc. (NKTX)
1 filing
$91.0K
SpyGlass Pharma, Inc. (SGP)
1 filing
$32.4K
$32.4K bought
Acrivon Therapeutics, Inc. (ACRV)
1 filing
$30.8K
Inhibikase Therapeutics, Inc. (IKT)
2 filings
$18.0K
Tyra Biosciences, Inc. (TYRA)
1 filing
$9.1K
Solid Biosciences Inc. (SLDB)
1 filing
$0
Trading History
| Nov 18 | SGP SpyGlass Pharma, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $32.4K |
| Nov 17 | PEPG PepGen Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $43.1M |
| Nov 3 | BBTX Bambusa Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $46.6M |
| Nov 2 | LENZ LENZ Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $9.1M |
| Oct 29 | BBTX Bambusa Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Oct 7 | WVE Wave Life Sciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Grant | $240.0K |
| Oct 5 | VOR Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Exercise | $12.8K |
| Sep 30 | CLYM Climb Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Exercise | $390.2K |
| Sep 21 | SION Sionna Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $21.8M |
| Sep 17 | TYRA Tyra Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $9.1K |
| Sep 14 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $169.3K |
| Sep 8 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $149.6K |
| Aug 26 | VOR Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Exercise | $5.6K |
| Aug 14 | SEPN Septerna, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $63.5M |
| Jul 31 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $455.7K |
| Jul 31 | IKT Inhibikase Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $18.0K |
| Jul 28 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $412.8K |
| Jul 23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $2.6M |
| Jul 23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $58.3K |
| Jul 22 | FRNM Freenome, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Grant | $52.6M |
| Jul 22 | FRNM Freenome, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jul 22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $6.9M |
| Jul 21 | VOR Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $4.2K |
| Jul 20 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $1.4M |
| Jul 17 | IKT Inhibikase Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jul 14 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $194.0K |
| Jul 1 | CLYM Climb Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $939.0K |
| Jun 30 | SEPN Septerna, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $560.1K |
| Jun 29 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $292.1K |
| Jun 26 | SPRY ARS Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $316.2K |
| Jun 24 | SLDB Solid Biosciences Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 22 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $145.9K |
| Jun 22 | PEPG PepGen Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $60.9K |
| Jun 22 | ACRV Acrivon Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $30.8K |
| Jun 18 | SION Sionna Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $636.9K |
| Jun 17 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $1.7M |
| Jun 16 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $4.6M |
| Jun 16 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $173.8K |
| Jun 15 | LENZ LENZ Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $146.5K |
| Jun 15 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $423.8M |
| Jun 12 | JANX Janux Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Grant | $211.7K |
| Jun 12 | VOR Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $805.4K |
| Jun 11 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $253.6K |
| Jun 11 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $7.7M |
| Jun 11 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $404.3K |
| Jun 11 | NKTX Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $91.0K |
| Jun 10 | BCAX Bicara Therapeutics Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $400.4K |
| Jun 9 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 8 | CLYM Climb Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $422.0K |
| Jun 5 | ABOS Acumen Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Grant | $121.9K |
50 filings+